Ritholtz Wealth Management decreased its position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by ...

Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) shot up 7.6% during mid-day trading on Monday after Raymond James raised their price target on the stock from $26.00 to $28.00.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand ... paradigm for each individual” and determine the best way for them to manage the disease. According to Martin ...

The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...